SYK 8-K Current Reports
STRYKER CORP - 264 current reports
STRYKER CORP 8-K Report, Corporate Update (Jun 26, 2026)
Stryker Corporation (SYK) has filed a Form 8-K to provide updated segment reporting information. This filing details a change in organizational structure initiated in the first quarter of 2026, which combines the orthopaedic instruments portfolio from its Instruments business with the Mako and enabling technologies portfolio from its Other Orthopaedics business to form a new 'Ortho Tech' business. This strategic move aims to simplify the customer experience and accelerate market speed through focused innovation. While this reorganization creates a new internal business unit, Stryker will continue to report its financial results under its two existing reportable segments: MedSurg and Neurotechnology, and Orthopaedics. The primary purpose of this 8-K is to comply with SEC regulations requiring the recasting of prior period financial statements in certain future filings (like registration statements or proxy statements) to reflect these segment changes. Investors should note that this filing does not restate previously issued financial statements or update the Management's Discussion and Analysis from the 2025 10-K, but provides recast information for the year ended December 31, 2025, as detailed in Exhibit 99.1.
STRYKER CORP 8-K Report, Executive Changes (May 20, 2026)
Stryker Corporation (SYK) announced a leadership transition in its accounting department, with Vice President and Chief Accounting Officer William E. Berry, Jr. retiring effective September 1, 2026. Emily Baculik, currently Vice President, Corporate Controller, will assume the role of Chief Accounting Officer starting the same date. This transition involves a planned advisory period for Mr. Berry and a compensation adjustment for Ms. Baculik as she steps into her new role. Investors should note the smooth handover facilitated by Mr. Berry's advisory role and the clear succession plan. Ms. Baculik brings extensive experience from various finance and accounting leadership positions within Stryker and other publicly traded companies. The filing details the terms of Mr. Berry's transition agreement, including continued salary and bonus eligibility, and Ms. Baculik's new compensation structure, which includes a base salary increase and potential long-term incentive awards.
STRYKER CORP 8-K Report, Shareholder Vote Results (May 8, 2026)
Stryker Corporation (SYK) filed an 8-K on May 8, 2026, reporting the results of its Annual Meeting of Shareholders held on May 6, 2026. The primary focus of the filing is the voting outcomes on three key proposals: the election of directors, the ratification of the independent registered public accounting firm, and an advisory vote on executive compensation. All proposals received substantial shareholder support, indicating a positive sentiment from the company's investors regarding its governance and financial oversight. Specifically, all ten nominated directors were overwhelmingly elected, demonstrating continued confidence in the company's leadership. Shareholders also ratified the appointment of Ernst & Young LLP as the independent auditor for 2026, a standard but important vote for financial transparency. Furthermore, the advisory resolution on executive compensation was approved, suggesting that shareholders are largely in agreement with the company's compensation practices for its named executive officers.
STRYKER CORP 8-K Report, Financial Results (Apr 30, 2026)
Stryker Corporation (SYK) has filed a Form 8-K on April 30, 2026, to report its first quarter 2026 operating results. The primary purpose of this filing is to provide investors with the company's financial performance and condition for the period ending March 31, 2026, as detailed in the accompanying press release (Exhibit 99.1). While this report itself is informational, the press release contains the substantive details of the company's Q1 2026 performance. Investors should refer to the press release, Exhibit 99.1, for specific financial metrics, revenue figures, profitability, and any forward-looking statements or guidance provided by Stryker management. The filing serves as the official mechanism to disseminate this critical quarterly update. It's important to note the disclaimer stating the information furnished is not deemed "filed" under Section 18 of the Exchange Act, meaning it's not subject to the same liabilities for misstatements or omissions as formally filed documents, though it is still material information.
STRYKER CORP 8-K/A Report, Cybersecurity Incident (Apr 9, 2026)
This 8-K/A filing from Stryker Corp. (SYK) provides an important update regarding a material cybersecurity incident first disclosed in March 2026. The company confirms that the incident, which occurred on March 11, 2026, caused disruptions to its business operations. While an investigation is ongoing with the help of third-party experts and law enforcement, Stryker has determined the incident had a material impact on its operations and, consequently, its financial results for the first quarter of 2026. Despite the Q1 financial impact, Stryker believes the incident is not reasonably likely to materially impact its full-year 2026 guidance. As of the filing date, the company has fully restored operations across its global manufacturing network, and its commercial, ordering, and distribution systems are back online. Investors should note that the company plans to discuss these financial results and guidance components in more detail during its Q1 2026 earnings report scheduled for April 30, 2026.
STRYKER CORP 8-K Report, Regulation FD Disclosure (Mar 23, 2026)
Stryker Corporation (SYK) has filed a Form 8-K on March 23, 2026, providing an update on a previously disclosed cybersecurity incident. The company, with the assistance of third-party experts including Palo Alto Networks' Unit 42 and law enforcement, has been working to contain and mitigate the impact of the incident and restore operations. Initial findings suggest the threat actor used a malicious file to execute commands and hide activity, but this file was not capable of spreading. As of the report date, Stryker has not identified malicious activity directed at its customers, suppliers, vendors, or partners, and a General Assurance Letter (Exhibit 99.1) from its advisors reaffirms the belief that the incident is contained and no evidence of threat actor access to external systems has been found. However, the incident did cause disruptions to Stryker's corporate network environment, specifically including its Microsoft environment. The full scope, nature, and potential operational and financial impact of the incident are still under ongoing assessment, and the company has not yet determined if it will have a material impact.
STRYKER CORP 8-K Report, Regulation FD Disclosure (Mar 12, 2026)
Stryker Corporation (SYK) filed an 8-K on March 12, 2026, providing an update on a previously disclosed cybersecurity incident. This incident has impacted the Company's global Microsoft environment, leading to ongoing disruptions in critical operations such as order processing, manufacturing, and shipping. While patient-related services and connected products are not believed to have been affected, the full scope and financial impact of the incident remain under investigation and are currently unknown. Investors should be aware that the company is actively managing the situation, with the Chief Information Security Officer providing updates to stakeholders. However, the material operational and financial consequences are yet to be determined. The filing includes cautionary statements regarding forward-looking information, highlighting potential risks including data integrity issues, system restoration delays, and potential adverse effects on operations, financial condition, and relationships with third parties.
STRYKER CORP 8-K Report, Corporate Update (Mar 11, 2026)
Stryker Corporation (SYK) has disclosed a significant cybersecurity incident that occurred on March 11, 2026, impacting its global Microsoft environment and causing widespread disruption to its IT systems and business applications. The company has activated its cybersecurity response plan and is investigating the incident with the support of external experts. While initial indications suggest no ransomware or malware and that the incident is contained, the full scope, nature, and operational and financial impacts are still under investigation. Investors should note that the company is actively working to restore affected systems and has business continuity measures in place to maintain operations and support customers. However, the timeline for full restoration remains unknown, and Stryker has not yet determined if the incident will have a material impact. The company's forward-looking statements in the filing highlight potential risks including data integrity issues, restoration delays, operational disruptions, financial impacts, litigation, and reputational damage.
STRYKER CORP 8-K Report, Financial Results (Jan 29, 2026)
Stryker Corporation (SYK) has filed an 8-K report on January 28, 2026, to announce its fourth quarter and full-year 2025 operating results and provide its outlook for 2026. This filing primarily directs investors to a press release, included as Exhibit 99.1, which contains the detailed financial performance and future guidance. Investors should refer to this press release for comprehensive information regarding the company's recent financial health and its strategic expectations for the upcoming fiscal year. The information presented is furnished and not deemed 'filed' for regulatory purposes, underscoring the importance of reviewing the press release directly.
STRYKER CORP 8-K Report, Executive Changes (Dec 4, 2025)
Stryker Corporation (SYK) announced significant leadership changes effective January 1, 2026. Spencer Stiles, currently Group President of Orthopaedics, will be promoted to President and Chief Operating Officer. Dylan Crotty, previously President of Instruments, will succeed Mr. Stiles as Group President, Orthopaedics. Both executives have long tenures with the company and have held various leadership roles across key business segments. These executive appointments come with updated compensation packages, including base salary increases, bonus targets, and recommendations for substantial long-term incentive awards for both Mr. Stiles and Mr. Crotty in early 2026. The compensation details include a mix of stock options and performance stock units, reflecting a commitment to retaining and incentivizing key leadership talent. Investors should note these moves signal continued internal development and a focus on experienced leadership within Stryker's operational structure.
STRYKER CORP 8-K Report, Financial Results (Oct 30, 2025)
Stryker Corporation has filed an 8-K report on October 30, 2025, to announce its third quarter 2025 operating results via a press release dated October 30, 2025. This filing serves as the primary vehicle for disclosing the company's financial performance for the period ending on or around September 30, 2025. Investors should refer to the attached press release (Exhibit 99.1) for detailed financial figures, operational achievements, and forward-looking statements that were shared by the company. The information furnished within this report, specifically the press release, is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into any other SEC filings unless explicitly stated. This means the standard liability provisions for filed documents do not apply to this particular disclosure. Investors are encouraged to review the press release for a comprehensive understanding of Stryker's Q3 2025 performance and any associated commentary from management.
STRYKER CORP 8-K Report, Financial Results (Jul 31, 2025)
Stryker Corporation (SYK) has filed an 8-K report on July 30, 2025, to announce its second quarter 2025 operating results via a press release dated July 31, 2025. While the full details of the results are contained within the attached press release (Exhibit 99.1), this filing serves as formal notification to the market. Investors should refer to Exhibit 99.1 for specific financial performance, key operational achievements, and management commentary regarding the second quarter. The company is providing this information as required, and the details within the press release will offer insights into Stryker's performance, including revenue, profitability, and any forward-looking statements or guidance provided by management. It's important for investors to review the attached exhibit for a comprehensive understanding of the company's recent financial condition and operational outcomes.
STRYKER CORP 8-K Report, Executive Changes (May 13, 2025)
Stryker Corporation (SYK) held its Annual Meeting of Shareholders on May 8, 2025, where significant corporate governance and compensation-related proposals were approved. The most notable outcomes include the shareholder approval of the amended and restated 2011 Long-Term Incentive Plan, the 2011 Performance Incentive Award Plan, and the 2008 Employee Stock Purchase Plan. These approvals allow for an increase in the number of shares available for issuance under these plans and extend their durations, which is crucial for ongoing employee compensation and retention strategies. Additionally, all ten incumbent directors were re-elected, demonstrating continued shareholder confidence in the current board's leadership. The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was also ratified. The advisory vote on executive compensation also received shareholder approval. These outcomes indicate shareholder alignment with the company's governance and compensation frameworks, suggesting stability and continued support for management's strategic direction.
STRYKER CORP 8-K Report, Financial Results (May 1, 2025)
Stryker Corporation (SYK) has filed an 8-K report on May 1, 2025, to announce its first quarter 2025 operating results, as detailed in a press release issued on the same date. While the 8-K itself is primarily procedural, it directs investors to the attached press release (Exhibit 99.1) for the substantive financial and operational details of the quarter ending April 30, 2025. Investors should refer to this press release for specific figures on revenue, earnings, segment performance, and any forward-looking guidance provided by the company. The filing also includes the interactive data file for the cover page. It's important to note that the information furnished in this report, including the press release, is not deemed 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same legal implications as a formally filed document unless specifically incorporated by reference into another filing. Investors should rely on the information within the press release for key performance indicators and strategic updates for Q1 2025.
STRYKER CORP 8-K Report, Material Agreement (Feb 27, 2025)
Stryker Corporation (SYK) has announced the execution of a new $3.0 billion revolving credit agreement, replacing its previous facility established in October 2021. This new agreement, effective February 25, 2025, extends the maturity date to February 25, 2030, providing long-term financial flexibility. A key feature is the introduction of an acquisition holiday provision, allowing a temporary increase in the maximum permitted leverage ratio to 4.75:1 from 3.75:1 in connection with material acquisitions, offering strategic agility for potential growth opportunities. While the underlying covenants and representations remain largely consistent with the prior agreement, the new credit facility outlines specific interest rates tied to various benchmarks (Eurocurrency Rate, Term SOFR, Term CORRA, or Base Rate) plus applicable margins, which are influenced by Stryker's credit ratings. The facility fee for undrawn amounts also varies based on credit ratings. This refinancing demonstrates Stryker's proactive approach to managing its capital structure and ensuring access to liquidity to support ongoing operations and strategic initiatives.
STRYKER CORP 8-K Report, Acquisition Completed (Feb 19, 2025)
Stryker Corporation (SYK) has officially announced the completion of its acquisition of Inari Medical, Inc. (Inari) as of February 19, 2025. This significant transaction, valued at approximately $4.94 billion in cash, was executed through a merger between Stryker's wholly owned subsidiary, Eagle 1 Merger Sub, Inc., and Inari. The acquisition was made under the terms of a previously announced Agreement and Plan of Merger dated January 6, 2025. This move represents a substantial strategic expansion for Stryker, likely aimed at bolstering its presence in a key medical device sector. Investors should monitor how the integration of Inari's business and products impacts Stryker's future revenue streams, profitability, and market share. The substantial cash outlay indicates a strong commitment to growth, and the success of this acquisition will be a key factor in evaluating Stryker's performance in the coming quarters and years.
STRYKER CORP 8-K Report, Material Agreement (Feb 10, 2025)
Stryker Corporation (SYK) announced the completion of a significant public offering of senior notes, raising a total of $3 billion. This offering consists of four tranches with varying maturities and interest rates: $500 million of 4.550% Notes due 2027, $700 million of 4.700% Notes due 2028, $800 million of 4.850% Notes due 2030, and $1 billion of 5.200% Notes due 2035. The proceeds from the issuance will be strategically allocated, with the 2030 and 2035 Notes intended to fund the tender offer for the acquisition of Inari Medical, Inc., and related expenses. The proceeds from the 2027 and 2028 Notes will be used for general corporate purposes, including working capital and potential acquisitions. The filing also outlines certain conditions related to the Inari Medical acquisition, specifically regarding the 2030 and 2035 Notes. Should the Inari acquisition not be consummated under specified terms by a certain date, these particular notes will be subject to a special mandatory redemption at 101% of their principal amount plus accrued interest. This structure highlights the company's commitment to its strategic growth initiatives while managing financial obligations and potential deal contingencies.
STRYKER CORP 8-K Report, Executive Changes (Feb 10, 2025)
Stryker Corporation (SYK) has announced a director change in a recent 8-K filing. Allan Golston, a long-standing member of the Board of Directors, has informed the company of his intention to retire from the Board. His retirement is set to be effective at the upcoming annual meeting of shareholders, anticipated on May 8, 2025. Mr. Golston will continue his directorial duties until that date. Importantly, the company has stated that Mr. Golston's decision to retire is not a result of any disagreements with the Company's management or its operations. This indicates a planned and orderly transition, which is generally viewed positively by investors as it avoids potential governance concerns. Investors should note this change as part of the ongoing board composition and governance updates for Stryker.
STRYKER CORP 8-K Report, Executive Changes (Jan 28, 2025)
Stryker Corporation (SYK) has announced a significant leadership transition within its finance department. Effective April 1, 2025, current Vice President, Chief Financial Officer Glenn S. Boehnlein will retire from his executive role. To ensure a smooth handover, Mr. Boehnlein will transition to an Advisor to the CEO role until March 31, 2026, continuing to receive his current base salary and eligibility for bonuses. Concurrently, Preston W. Wells, currently the Vice President, Group Chief Financial Officer for Orthopaedics, has been appointed as the new Vice President, Chief Financial Officer. Mr. Wells, with extensive internal experience in financial planning, investor relations, and orthopaedics finance, will see his base salary increase to $725,000, with a bonus target of 85%. He is also slated for a significant long-term incentive award in February 2025, valued at approximately $3 million, comprising stock options and performance stock units. This transition signals a promotion from within and a structured handover process.
STRYKER CORP 8-K Report, Financial Results (Jan 28, 2025)
Stryker Corporation has filed an 8-K report detailing its fourth quarter and full-year 2024 operating results, alongside its initial outlook for 2025. This filing primarily serves to announce these results via a press release, which is attached as an exhibit. Investors should refer to this press release for specific financial performance metrics, including revenue, earnings, and any segment-specific data for the reported periods. The press release also provides forward-looking guidance, offering insights into management's expectations for the company's performance in the upcoming fiscal year.
STRYKER CORP 8-K Report, Material Agreement (Jan 7, 2025)
Stryker Corporation (SYK) has announced a significant strategic move through an Agreement and Plan of Merger with Inari Medical, Inc., filed on January 6, 2025. The transaction involves Stryker initiating a tender offer to acquire all outstanding shares of Inari Medical for $80.00 per share in cash. This acquisition aims to expand Stryker's presence in the medical device market, likely in areas related to Inari's specialization in minimally invasive treatments for venous and arterial diseases. The deal is subject to customary closing conditions, including a majority tender of Inari's shares and regulatory approvals, such as the Hart-Scott-Rodino Antitrust Improvements Act. The tender offer is expected to commence shortly and will remain open for a minimum of 20 business days. Following a successful tender offer, Stryker intends to complete the acquisition through a merger. Investors should note the 'no-shop' clause for Inari, though exceptions exist for superior proposals, and a termination fee of $163 million if the deal is not completed under specific circumstances, such as Inari accepting a superior offer or Stryker terminating due to a change in Inari's recommendation.
STRYKER CORP 8-K Report, Financial Results (Oct 29, 2024)
Stryker Corporation (SYK) has filed an 8-K report on October 28, 2024, to announce its third quarter 2024 operating results via a press release issued on October 29, 2024. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification that the company has released its quarterly performance update. Investors should refer to the attached press release (Exhibit 99.1) for specific details on revenue, earnings, segment performance, and any forward-looking guidance. This filing is primarily procedural, ensuring that the market is officially informed of the Q3 2024 results. The attached press release is expected to contain key financial metrics and operational highlights that will enable investors to assess Stryker's performance and outlook. As this information is being furnished and not filed in the traditional sense, it's important to note that it won't be automatically incorporated into previous SEC filings unless specifically referenced.
STRYKER CORP 8-K Report, Material Agreement (Sep 11, 2024)
Stryker Corporation (SYK) has announced the successful completion of two significant public offerings of senior notes, raising a total of approximately €1.4 billion (or $1.53 billion USD) in Euro Notes and $1.5 billion USD in U.S. Dollar Notes. The Euro Notes consist of €800 million of 3.375% Notes due 2032 and €600 million of 3.625% Notes due 2036. The U.S. Dollar Notes comprise $750 million of 4.250% Notes due 2029 and $750 million of 4.625% Notes due 2034. The net proceeds from these offerings are earmarked for significant corporate actions. Primarily, the funds will be used to repay €500 million of floating rate notes due 2024 and €850 million of 0.250% notes due 2024 at maturity. The remaining proceeds will be allocated to general corporate purposes, including working capital, potential acquisitions, and other business opportunities, as well as further debt repayment or retirement. This move indicates active management of Stryker's capital structure and strategic financial planning.
STRYKER CORP 8-K Report, Financial Results (Jul 30, 2024)
Stryker Corporation (SYK) filed an 8-K on July 30, 2024, to announce its second quarter 2024 operating results via a press release dated July 30, 2024. This filing serves as the primary communication channel for investors to access the company's latest financial performance and operational updates for the period ending around July 29, 2024. The key takeaway for investors is that Stryker has reported its Q2 2024 results, and the detailed financial performance and condition are available within the attached press release (Exhibit 99.1). While the 8-K itself does not contain the detailed financial figures, it directs investors to the comprehensive press release. Investors should refer to Exhibit 99.1 for specific metrics such as revenue, earnings per share, segment performance, and any forward-looking guidance provided by the company. It's important to note that the information furnished in this report, including the press release, is not considered "filed" for Section 18 purposes and is not automatically incorporated into other SEC filings unless explicitly stated.
STRYKER CORP 8-K Report, Shareholder Vote Results (May 14, 2024)
Stryker Corporation (SYK) filed an 8-K on May 13, 2024, detailing the results of its Annual Meeting of Shareholders held on May 9, 2024. The meeting focused on shareholder voting on several key proposals, including the election of directors, ratification of the independent auditor, and advisory votes on executive compensation and a political spending transparency proposal. All ten director nominees were overwhelmingly elected, indicating strong shareholder confidence in the current board's leadership and governance. The company also secured shareholder approval for its chosen independent registered public accounting firm, Ernst & Young LLP, for the fiscal year 2024. Furthermore, the advisory vote on the compensation of named executive officers received majority support. However, a shareholder proposal seeking greater transparency in political spending was not approved by the majority of votes cast, highlighting a divergence of opinion on this specific governance matter.
STRYKER CORP 8-K Report, Financial Results (Apr 30, 2024)
Stryker Corporation (SYK) has filed an 8-K report on April 30, 2024, primarily to disclose its first quarter 2024 operating results, as detailed in a press release issued on the same date. While the 8-K itself is a procedural filing referencing the press release (Exhibit 99.1), the investor focus will be on the financial and operational performance announced in that release. Investors should review the press release for specific details on revenue, earnings, segment performance, and any forward-looking guidance provided by the company for the upcoming quarters.
STRYKER CORP 8-K Report, Financial Results (Jan 30, 2024)
Stryker Corporation has filed an 8-K report detailing its fourth quarter and full-year 2023 operating results, along with its financial outlook for 2024. The company announced these results via a press release issued on January 30, 2024, which is attached as an exhibit to this filing. Investors should pay close attention to the specific financial metrics and growth projections provided in the press release to understand the company's recent performance and future expectations. This filing primarily serves to disseminate the official earnings announcement, which typically includes key performance indicators such as revenue, net income, earnings per share (EPS), and segment-specific results. The provided 2024 outlook will be crucial for assessing Stryker's anticipated growth trajectory and potential challenges or opportunities in the upcoming fiscal year. Investors are advised to review the attached press release (Exhibit 99.1) for the detailed financial data and forward-looking statements.
STRYKER CORP 8-K Report, Material Agreement (Dec 11, 2023)
Stryker Corporation (SYK) has announced the completion of a public offering of €600,000,000 aggregate principal amount of its 3.375% Notes due 2028. The offering, which closed on December 11, 2023, utilized the company's existing shelf registration statement and prospectus. The net proceeds are expected to be approximately €597 million (or $649 million based on the specified exchange rate), which Stryker intends to use for general corporate purposes. These new notes carry a fixed annual interest rate of 3.375%, with interest payments due annually on December 11, commencing in 2024, and the principal maturing on December 11, 2028. The indenture governing these notes includes covenants that restrict certain actions like incurring additional liens or engaging in sale-and-leaseback transactions. Importantly, a change of control event, coupled with a downgrade to below investment grade by both Moody's and S&P, would trigger an offer to repurchase the notes at 101% of the principal amount.
STRYKER CORP 8-K Report, Material Agreement (Dec 8, 2023)
Stryker Corporation (SYK) announced on December 8, 2023, the completion of a public offering of $600 million in aggregate principal amount of 4.850% Notes due 2028. The company expects to receive net proceeds of approximately $594 million, which will be used for general corporate purposes. This debt issuance adds to Stryker's capital structure and provides financial flexibility for its ongoing operations and strategic initiatives. In addition to the debt offering, the company disclosed that Dr. Srikant Datar, a member of the Board of Directors, will retire from the Board effective as of the company's annual meeting of shareholders expected to be held on May 9, 2024. This departure is not a result of any disagreement with the company. Investors should monitor how these proceeds are deployed and assess any potential impact of Dr. Datar's departure on board dynamics.
STRYKER CORP 8-K Report, Financial Results (Nov 2, 2023)
Stryker Corporation (SYK) announced its third quarter 2023 operating results via a press release filed on November 2, 2023. The filing primarily serves to attach this press release, which contains the company's financial performance details for the period ending November 1, 2023. Investors should refer to the press release (Exhibit 99.1) for specific financial metrics, including revenue, earnings, and guidance, as this 8-K filing itself does not contain the detailed results but directs to the accompanying document. While the 8-K filing is procedural, the attached press release is the crucial source of information for understanding Stryker's recent performance and future outlook. Investors are encouraged to review the press release for a comprehensive understanding of the quarter's operational and financial standing, including any commentary on market conditions, segment performance, and strategic initiatives.
STRYKER CORP 8-K Report, Financial Results (Aug 3, 2023)
Stryker Corporation (SYK) has filed an 8-K report on August 3, 2023, primarily to announce its second quarter 2023 operating results via a press release dated August 3, 2023. This filing serves as notification to investors about the company's financial performance for the recently concluded quarter. The key takeaway for investors is that the detailed financial and operational results are contained within the attached press release (Exhibit 99.1), which provides the most current information on the company's performance. While the 8-K itself doesn't contain the specific figures, it directs investors to the press release for details on revenue, earnings, and any forward-looking statements or management commentary regarding the quarter's performance and future outlook. Investors should review Exhibit 99.1 to understand Stryker's financial health, operational trends, and strategic initiatives as presented by the company.
STRYKER CORP 8-K Report, Material Agreement (Jun 16, 2023)
Stryker Corporation (SYK) has filed an 8-K report on June 15, 2023, to announce an amendment to its existing Credit Agreement originally dated October 26, 2021. This amendment, effective June 15, 2023, primarily transitions the credit facility from LIBOR-based benchmark interest rates to SOFR-based benchmark rates. This is a standard market practice as LIBOR is being phased out globally.
STRYKER CORP 8-K Report, Shareholder Vote Results (May 16, 2023)
This 8-K filing from Stryker Corporation details the outcomes of its Annual Meeting of Shareholders held on May 10, 2023. The key takeaway for investors is the overwhelming shareholder support for the company's proposed actions. All ten nominated directors were overwhelmingly elected, indicating strong confidence in the current board's leadership and governance. Furthermore, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2023, a crucial vote for maintaining financial transparency and integrity. The advisory vote on executive compensation, often a point of scrutiny for investors, also received strong approval, suggesting satisfaction with the company's compensation practices. Shareholders also overwhelmingly supported holding an annual advisory vote on executive compensation, aligning with the Board's recommendation and indicating a preference for regular shareholder input on this matter. The only proposal that did not pass was a shareholder proposal related to political disclosure, which received significant opposition.
STRYKER CORP 8-K Report, Financial Results (May 1, 2023)
Stryker Corporation (SYK) has filed an 8-K report on May 1, 2023, to disclose its first quarter 2023 operating results, as announced in a press release dated May 1, 2023. This filing primarily serves to attach the press release detailing the company's financial performance and operational updates for the period ending April 30, 2023. Investors should refer to the attached press release for specific financial metrics and management commentary regarding the quarter's results. While the 8-K itself is brief, its main purpose is to provide access to the detailed financial results. The information furnished, including the press release, is not considered "filed" for certain regulatory purposes unless explicitly incorporated by reference into future filings. Therefore, investors seeking a comprehensive understanding of Stryker's Q1 2023 performance should carefully review Exhibit 99.1 attached to this filing.
STRYKER CORP 8-K Report, Financial Results (Jan 31, 2023)
Stryker Corporation (SYK) filed an 8-K on January 31, 2023, primarily to announce its fourth quarter and full-year 2022 financial results and provide its outlook for 2023. The key takeaway for investors is that the company has released its performance for the most recent periods and has set expectations for the upcoming year, allowing for informed investment decisions. The accompanying press release (Exhibit 99.1) contains the detailed financial information and forward-looking statements. Investors should review the press release attached to this filing for a comprehensive understanding of Stryker's financial performance, including revenue, earnings, and any segment-specific data for Q4 and the full year 2022. The 2023 outlook provided will be critical for assessing future growth prospects and the company's ability to meet market expectations. This filing serves as the official channel for these important updates.
STRYKER CORP 8-K Report, Bylaw Amendment (Nov 15, 2022)
This 8-K filing by Stryker Corporation (SYK) primarily details amendments to its corporate bylaws, effective November 1, 2022. The most significant change requires compliance with the "universal proxy card" rules (Rule 14a-19) for shareholders wishing to nominate director candidates. This amendment aims to standardize and clarify the director nomination process in line with current SEC regulations, ensuring a more streamlined and equitable approach to shareholder engagement in board elections. While this filing does not report on financial performance or significant operational changes, investors should note the proactive adjustment to corporate governance procedures. The updated bylaws reflect Stryker's commitment to adhering to regulatory best practices and facilitating shareholder participation in corporate governance. The full text of these amendments is available as an exhibit to this filing.
STRYKER CORP 8-K Report, Financial Results (Oct 31, 2022)
Stryker Corporation has filed an 8-K report on October 31, 2022, to announce its third quarter 2022 operating results. The core of this filing is the press release, attached as Exhibit 99.1, which provides investors with the company's latest financial performance and operational updates. While the 8-K itself is a procedural document for this event, the attached press release contains the crucial details regarding Stryker's financial condition and results of operations for the period ending October 30, 2022. Investors should pay close attention to the specific metrics and commentary presented in the press release to understand Stryker's performance drivers, revenue growth, profitability, and any forward-looking statements or guidance provided. This information is essential for assessing the company's current trajectory and future prospects within the medical technology sector.
STRYKER CORP 8-K Report, Financial Results (Jul 26, 2022)
Stryker Corporation (SYK) filed an 8-K on July 26, 2022, to report its second quarter 2022 operating results, as detailed in a press release issued on the same date. This filing serves to inform investors about the company's recent financial performance and operational updates. The press release, attached as Exhibit 99.1, contains the detailed financial data and commentary from the company regarding its Q2 2022 performance. Investors reviewing this 8-K should focus on the information contained within the referenced press release for key financial metrics, management's discussion of results, and any forward-looking statements or guidance provided. While the 8-K itself is a formal notification, the substance of Stryker's Q2 performance is accessible through the attached exhibit, which typically includes revenue, earnings per share, and segment-specific performance.
STRYKER CORP 8-K Report, Shareholder Vote Results (May 9, 2022)
Stryker Corporation (SYK) filed an 8-K report on May 9, 2022, detailing the outcomes of its Annual Meeting of Shareholders held on May 4, 2022. The report primarily concerns the voting results on several key proposals, offering insights into shareholder sentiment and corporate governance. Notably, all ten nominated directors were overwhelmingly elected, indicating strong shareholder confidence in the current board leadership and strategy. Furthermore, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022, a routine but important vote for financial transparency and audit integrity. The meeting also saw shareholders approve the advisory vote on executive compensation, suggesting alignment between management's pay practices and shareholder expectations. However, a shareholder proposal related to proxy access terms was not approved, indicating a divergence of opinion on this specific governance matter. Overall, the filing reflects stable shareholder support for the company's leadership and financial oversight, with a notable instance of disagreement on a governance-related proposal.
STRYKER CORP 8-K Report, Regulation FD Disclosure (May 5, 2022)
Stryker Corporation (SYK) announced changes to its Board of Directors leadership and committee assignments through an 8-K filing on May 4, 2022. The most significant change involves Sherilyn S. McCoy succeeding Allan C. Golston as the Lead Independent Director. Additionally, Mary K. Brainerd has replaced Ms. McCoy as the Chair of the Governance and Nominating Committee. These leadership transitions are effective as of May 3, 2022. Investors should note these changes as they can sometimes signal shifts in governance oversight or strategic focus, although no specific strategic changes were detailed in this filing. The press release accompanying this disclosure provides the full breakdown of the updated committee memberships.
STRYKER CORP 8-K Report, Financial Results (Apr 28, 2022)
Stryker Corporation (SYK) filed an 8-K on April 27, 2022, to report its first quarter 2022 operating results. The filing primarily directs investors to the press release issued on April 28, 2022, which contains the detailed financial performance for the quarter ending March 31, 2022. This report serves as official notification of the earnings release and includes the press release as an exhibit, making it the primary source of information for investors seeking to understand SYK's performance during the first quarter of 2022.
STRYKER CORP 8-K Report, Material Agreement (Feb 25, 2022)
Stryker Corporation (SYK) has announced the entry into a new $1.5 billion Term Loan Agreement on February 22, 2022. This agreement, with a maturity date of February 22, 2025, provides the company with significant liquidity. Notably, Stryker has already drawn the full $1.5 billion principal amount on the closing date, indicating immediate deployment of these funds. The new loan features a financial covenant tied to a leverage ratio, with a maximum permitted ratio of 3.75:1. The agreement also includes an 'acquisition holiday' provision, allowing Stryker to temporarily increase this ratio to 4.75:1 for up to four consecutive fiscal quarters in connection with material acquisitions. This suggests a potential strategic focus on mergers and acquisitions, with the company proactively securing financing and flexibility for such activities.
STRYKER CORP 8-K Report, Acquisition Completed (Feb 23, 2022)
Stryker Corporation (SYK) announced the successful completion of its acquisition of Vocera Communications, Inc. for approximately $3.1 billion. This strategic move, finalized on February 22, 2022, involved a merger where Vocera continues as the surviving entity. The acquisition price includes the repayment of Vocera's outstanding convertible notes, indicating a comprehensive financial integration. This acquisition is a significant development for Stryker, likely aimed at expanding its offerings and market presence within the healthcare technology sector. Investors should monitor how this integration impacts Stryker's financial performance, including revenue growth, profitability, and potential synergies with its existing product lines. The substantial investment suggests a strong conviction in Vocera's technology and future growth potential.
STRYKER CORP 8-K Report, Financial Results (Jan 27, 2022)
Stryker Corporation (SYK) filed an 8-K on January 27, 2022, to report its fourth quarter and full-year 2021 operating results and provide its outlook for 2022. The company issued a press release detailing these financial and operational updates, which is attached as an exhibit to the filing. Investors should review this press release for detailed segment performance, profitability, and forward-looking guidance. This report serves as the primary communication channel for Stryker's recent financial performance and its strategic expectations for the upcoming year. Key metrics such as revenue growth, earnings per share, and any significant business developments or challenges are typically highlighted in such releases. Investors interested in Stryker's trajectory and its ability to meet market expectations should pay close attention to the forward-looking statements and guidance provided for 2022.
STRYKER CORP 8-K Report, Regulation FD Disclosure (Jan 14, 2022)
Stryker Corporation announced a significant change to its business segment reporting structure, effective December 31, 2021. The company is consolidating its operations into two distinct reportable segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. This realignment is driven by a shift in internal reporting and management structure, including changes in executive responsibilities with Group Presidents J. Andrew Pierce and Spencer S. Stiles overseeing the respective new segments. This change is intended to better reflect how Stryker manages its diverse business operations and will impact how historical product sales information is presented. The company has provided recast historical product sales data in Exhibit 99.1 to allow investors to analyze performance under the new segment structure. While this information is for informational purposes and not formally filed, it offers crucial context for understanding Stryker's future financial reporting and operational focus.
STRYKER CORP 8-K Report, Material Agreement (Jan 11, 2022)
Stryker Corporation (SYK) announced its entry into a material definitive agreement to acquire Vocera Communications, Inc. (Vocera) through a cash tender offer. Stryker, via its subsidiary Voice Merger Sub Corp., will commence an offer to purchase all outstanding shares of Vocera for $79.25 per share in cash. This acquisition represents a significant strategic move for Stryker, aiming to enhance its offerings in the healthcare technology space, particularly in areas related to secure communication and workflow solutions for healthcare professionals. The transaction is valued at approximately $79.25 per share, totaling a significant cash outlay for Stryker. The deal is subject to customary closing conditions, including the tender of a majority of Vocera's shares and antitrust approvals. Following the successful tender offer, Stryker plans to merge with Vocera, making it a wholly owned subsidiary. Investors should monitor the progress of the tender offer and the satisfaction of regulatory conditions, as this acquisition will impact Stryker's future growth and market position.
STRYKER CORP 8-K Report, Corporate Update (Jan 3, 2022)
Stryker Corporation (SYK) has filed an 8-K report detailing the resolution of a Dutch dividend withholding tax issue related to its acquisition of Wright Medical Group N.V. As a result of the acquisition's merger phase, a portion of the cash consideration ($1.85 per share) was withheld to cover potential Dutch Exit Tax. This tax was contingent on the enactment of a specific legislative proposal by January 1, 2022. As the legislative proposal was not enacted by the deadline, Stryker has instructed the paying agent to return the withheld Dutch Exit Tax Amount of $1.85 per share to the former Wright shareholders from whom it was originally deducted. This is a positive development for those former shareholders, as they will now receive the full intended merger consideration. Investors in Stryker should note this is primarily a resolution of a prior transaction detail and does not represent a new operational event for Stryker itself.
STRYKER CORP 8-K Report, Financial Results (Oct 28, 2021)
Stryker Corporation (SYK) announced its third quarter 2021 operating results via a press release filed on October 28, 2021. This 8-K filing primarily serves to attach this press release, which contains the company's detailed financial performance for the quarter ended October 27, 2021. Investors should refer to the attached press release (Exhibit 99.1) for comprehensive information on revenue, earnings, and other key financial metrics. While the 8-K itself does not provide the specific figures, it signals that Stryker has disclosed its quarterly performance. The press release is expected to offer insights into the company's operational strengths, segment performance (such as MedSurg, Orthopaedics, and Neurotechnology and Spine), and any notable business developments or challenges encountered during the third quarter. Investors are advised to review the full press release for a complete understanding of Stryker's financial standing and outlook.
STRYKER CORP 8-K Report, Executive Changes (Aug 18, 2021)
Stryker Corporation (SYK) has filed an 8-K report detailing significant leadership changes. Timothy J. Scannell, President and Chief Operating Officer, has announced his retirement effective March 31, 2023. To ensure a seamless transition, Mr. Scannell will transition to an Advisor to the CEO role starting October 1, 2021, continuing to receive his current salary and bonus eligibility. Effective October 1, 2021, the responsibilities of President and Chief Operating Officer will be jointly assumed by J. Andrew Pierce (Group President, MedSurg and Neurotechnology) and Spencer S. Stiles (Group President, Orthopedics and Spine), both of whom will report directly to CEO Kevin A. Lobo. Concurrently, Mr. Lobo will also assume the title of President, in addition to his current roles as Chair and CEO. These changes are designed to maintain operational continuity and leverage existing leadership strengths during the transition period.
STRYKER CORP 8-K Report, Financial Results (Jul 27, 2021)
Stryker Corporation announced its second quarter 2021 operating results via a press release filed on July 27, 2021. This filing, categorized under Item 2.02 (Results of Operations and Financial Condition), primarily directs investors to the attached press release (Exhibit 99.1) for detailed financial performance information. While the 8-K itself does not contain the specific figures, it signifies the official release of Q2 2021 earnings, which is a critical update for shareholders tracking the company's financial health and operational progress.